BRCA2 and neoplasm: For tumors that harbor a known alteration in HRR genes, such as BRCA1 or BRCA2, higher tumor mutational burden and a greater number of tumor-infiltrating lymphocytes has been seen in breast and ovarian cancer (77, 78).